Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we are herewith enclosing a copy of the Newspaper publication pertaining to the Audited FInancial Results (Standaole and Consolidated) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has submitted copies of newspaper clippings containing its Audited Financial Results (both Standalone and Consolidated) for the quarter and full year ended March 31, 2025. The results were published on June 14, 2025 in Trinity Mirror (English) and Makkal Kural (Tamil). The filing was made to BSE on June 15, 2025 by Whole-time Director Swaminathan G, under SEBI LODR Regulation 47. This is a routine compliance disclosure required of all listed companies. The actual financial numbers are not included in this filing and would be in the detailed results announcement.
No direct impact on the stock — this is a procedural filing confirming that the company's audited FY25 results were published in newspapers as required. Investors should look at the separate detailed financial results filing for actual numbers and performance insights.